← Leaderboards
John V Fahy
University Of California San Francisco
$35,378,030
Attributed
$35,378,030
Total exposure
18
Grants
15
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $8.4M · FY2005–25$10M$7.5M$5M$2.5M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$72,112,172 · 20
By mechanism
P01$51,877,620 · 12
R01$13,156,097 · 4
U10$4,028,815 · 1
UG1$2,200,190 · 1
P50$847,625 · 1
M01$1,825 · 1
Top collaborators
No co-investigators on record.
Most similar at University Of California San Francisco
Same institution · by research overlap
- John McLeod Griffiss$31,289,846
- James H. McKerrow$11,473,832
- Prescott G Woodruff$62,639,366
Others in their field
Top investigators on “Asthma”
- James E. Gern · University Of Wisconsin-Madison$159,588,264
- William W. Busse · University Of Wisconsin Madison$104,093,792
- Scott T Weiss · University Of California, San Diego$98,211,117
- David T Mauger · Pennsylvania State Univ Hershey Med Ctr$79,309,576
- Fernando D Martinez · University Of Arizona$66,357,737
- Wanda Phipatanakul · Boston Children'S Hospital$50,505,446
Research focus
AsthmaInflammationProgramsMucous Body SubstanceSputumMucinsHuman SubjectX-Ray Computed TomographyBaseResearch PersonnelBiologyPathologySamplingEpithelial CellsCellsCytokinePhenotypeEosinophilLungPathologicResponseLeadInterleukin-13Elasticity
Grant awards (97)
Phenotypic and biological features of mucus plugs in asthma$649,175
R01 · FY2025 · HL · contact PI
Evaluating the Impact of Metabolic Dysfunction on Asthma Pathology and Physiology$643,174
R01 · FY2025 · HL · contact PI
Phenotypic and biological features of mucus plugs in asthma$644,330
R01 · FY2024 · HL · contact PI
Evaluating the Impact of Metabolic Dysfunction on Asthma Pathology and Physiology$641,786
R01 · FY2024 · HL · contact PI
Exploring the biology of persistent type 2 airway niches in asthma$2,438,988
P01 · FY2023 · HL · contact PI
Evaluating the Impact of Metabolic Dysfunction on Asthma Pathology and Physiology$777,256
R01 · FY2023 · HL · contact PI
Phenotypic and biological features of mucus plugs in asthma$663,718
R01 · FY2023 · HL · contact PI
Epithelial cell reprogramming and mucus gel pathology in self-sustaining type 2 airway niches in asthma$562,594
P01 · FY2023 · HL · contact PI
Core B - Human Subjects Core$409,165
P01 · FY2023 · HL · contact PI
Administrative Core$71,968
P01 · FY2023 · HL · contact PI
Exploring the biology of persistent type 2 airway niches in asthma$2,438,988
P01 · FY2022 · HL · contact PI
Phenotypic and biological features of mucus plugs in asthma$680,407
R01 · FY2022 · HL · contact PI
Evaluating the Impact of Metabolic Dysfunction on Asthma Pathology and Physiology$575,043
R01 · FY2022 · HL · contact PI
Epithelial cell reprogramming and mucus gel pathology in self-sustaining type 2 airway niches in asthma$562,594
P01 · FY2022 · HL · contact PI
Core B - Human Subjects Core$409,165
P01 · FY2022 · HL · contact PI
Sequential, Multiple Assignment, Randomized Trial in Severe Asthma Protocol (SMART-SA)$328,922
UG1 · FY2022 · HL · contact PI
Administrative Core$71,968
P01 · FY2022 · HL · contact PI
Exploring the biology of persistent type 2 airway niches in asthma$2,438,988
P01 · FY2021 · HL · contact PI
Epithelial cell reprogramming and mucus gel pathology in self-sustaining type 2 airway niches in asthma$562,594
P01 · FY2021 · HL · contact PI
Core B - Human Subjects Core$409,165
P01 · FY2021 · HL · contact PI
Sequential, Multiple Assignment, Randomized Trial in Severe Asthma Protocol (SMART-SA)$370,141
UG1 · FY2021 · HL · contact PI
Administrative Core$71,968
P01 · FY2021 · HL · contact PI
Carbohydrate-based Therapy for Lung Disease$2,543,475
P01 · FY2020 · HL · contact PI
Exploring the biology of persistent type 2 airway niches in asthma$2,438,988
P01 · FY2020 · HL · contact PI
A thiol-saccharide therapy to treat COVID-19$768,543
P01 · FY2020 · HL · contact PI
Carbohydrate-based Therapy for Lung Disease$768,543
P01 · FY2020 · HL · contact PI
Epithelial cell reprogramming and mucus gel pathology in self-sustaining type 2 airway niches in asthma$562,594
P01 · FY2020 · HL · contact PI
Core B - Human Subjects Core$409,165
P01 · FY2020 · HL · contact PI
Sequential, Multiple Assignment, Randomized Trial in Severe Asthma Protocol (SMART-SA)$377,749
UG1 · FY2020 · HL · contact PI
Mucin Disulfide Links as a Mechanism of Pathologic Mucus in Airway Disease$328,322
P01 · FY2020 · HL · contact PI
Administrative Core$155,004
P01 · FY2020 · HL · contact PI
Administrative Core$71,968
P01 · FY2020 · HL · contact PI
Carbohydrate-based Therapy for Lung Disease$2,527,018
P01 · FY2019 · HL · contact PI
Exploring the biology of persistent type 2 airway niches in asthma$2,441,079
P01 · FY2019 · HL · contact PI
Epithelial cell reprogramming and mucus gel pathology in self-sustaining type 2 airway niches in asthma$559,732
P01 · FY2019 · HL · contact PI
Mechanism of mucus pathology in asthma exacerbations$454,877
R01 · FY2019 · HL · contact PI
Core B - Human Subjects Core$406,899
P01 · FY2019 · HL · contact PI
Sequential, Multiple Assignment, Randomized Trial in Severe Asthma Protocol (SMART-SA)$383,977
UG1 · FY2019 · HL · contact PI
Mucin Disulfide Links as a Mechanism of Pathologic Mucus in Airway Disease$328,360
P01 · FY2019 · HL · contact PI
Administrative Core$155,024
P01 · FY2019 · HL · contact PI
Administrative Core$71,559
P01 · FY2019 · HL · contact PI
Carbohydrate-based Therapy for Lung Disease$2,565,954
P01 · FY2018 · HL · contact PI
Mechanism of mucus pathology in asthma exacerbations$459,995
R01 · FY2018 · HL · contact PI
Sequential, Multiple Assignment, Randomized Trial in Severe Asthma Protocol (SMART-SA)$390,205
UG1 · FY2018 · HL · contact PI
Mucin Disulfide Links as a Mechanism of Pathologic Mucus in Airway Disease$372,445
P01 · FY2018 · HL · contact PI
Administrative Core$155,021
P01 · FY2018 · HL · contact PI
Carbohydrate-based Therapy for Lung Disease$2,468,866
P01 · FY2017 · HL · contact PI
Mucin Disulfide Links as a Mechanism of Pathologic Mucus in Airway Disease$532,936
P01 · FY2017 · HL · contact PI
Mechanism of mucus pathology in asthma exacerbations$462,472
R01 · FY2017 · HL · contact PI
Sequential, Multiple Assignment, Randomized Trial in Severe Asthma Protocol (SMART-SA)$349,196
UG1 · FY2017 · HL · contact PI
Administrative Core$154,744
P01 · FY2017 · HL · contact PI
Carbohydrate-based Therapy for Lung Disease$2,534,255
P01 · FY2016 · HL · contact PI
INNATE AND ADAPTIVE IMMUNE RESPONSES IN TH2-HIGH ASTHMA$2,366,154
P01 · FY2016 · HL · contact PI
Administrative Core$785,034
P01 · FY2016 · HL · contact PI
Mechanisms of airway Th2 inflammation in asthma$727,678
P01 · FY2016 · HL · contact PI
Clinical and Molecular Phenotypes of Severe Asthma$691,138
U10 · FY2016 · HL · contact PI
Mucin Disulfide Links as a Mechanism of Pathologic Mucus in Airway Disease$634,015
P01 · FY2016 · HL · contact PI
Mechanism of mucus pathology in asthma exacerbations$494,040
R01 · FY2016 · HL · contact PI
Administrative Core$155,702
P01 · FY2016 · HL · contact PI
INNATE AND ADAPTIVE IMMUNE RESPONSES IN TH2-HIGH ASTHMA$2,214,117
P01 · FY2015 · HL · contact PI
Clinical and Molecular Phenotypes of Severe Asthma$680,771
U10 · FY2015 · HL · contact PI
Mechanisms of airway Th2 inflammation in asthma$655,971
P01 · FY2015 · HL · contact PI
Administrative Core$442,174
P01 · FY2015 · HL · contact PI
INNATE AND ADAPTIVE IMMUNE RESPONSES IN TH2-HIGH ASTHMA$2,196,448
P01 · FY2014 · HL · contact PI
Clinical and Molecular Phenotypes of Severe Asthma$691,139
U10 · FY2014 · HL · contact PI
Mechanisms of airway Th2 inflammation in asthma$573,043
P01 · FY2014 · HL · contact PI
Human Subjects Core$532,760
P01 · FY2014 · HL · contact PI
Protein carbohydrate interactions in the pathophysiology of asthma exacerbations$504,036
R01 · FY2014 · HL · contact PI
Administrative Core$91,331
P01 · FY2014 · HL · contact PI
INNATE AND ADAPTIVE IMMUNE RESPONSES IN TH2-HIGH ASTHMA$2,121,199
P01 · FY2013 · HL · contact PI
Clinical and Molecular Phenotypes of Severe Asthma$691,139
U10 · FY2013 · HL · contact PI
Mechanisms of airway Th2 inflammation in asthma$554,159
P01 · FY2013 · HL · contact PI
Human Subjects Core$514,263
P01 · FY2013 · HL · contact PI
Protein carbohydrate interactions in the pathophysiology of asthma exacerbations$489,635
R01 · FY2013 · HL · contact PI
Administrative Core$88,160
P01 · FY2013 · HL · contact PI
INNATE AND ADAPTIVE IMMUNE RESPONSES IN TH2-HIGH ASTHMA$2,231,082
P01 · FY2012 · HL · contact PI
Clinical and Molecular Phenotypes of Severe Asthma$687,559
U10 · FY2012 · HL · contact PI
Mechanisms of airway Th2 inflammation in asthma$594,906
P01 · FY2012 · HL · contact PI
Human Subjects Core$538,473
P01 · FY2012 · HL · contact PI
Protein carbohydrate interactions in the pathophysiology of asthma exacerbations$514,322
R01 · FY2012 · HL · contact PI
Preventing fucose-dependent binding of aspergillus and pseudomonas to lung mucin$417,000
P50 · FY2012 · HL · contact PI
Administrative Core$92,312
P01 · FY2012 · HL · contact PI
Clinical and Molecular Phenotypes of Severe Asthma$587,069
U10 · FY2011 · HL · contact PI
Protein carbohydrate interactions in the pathophysiology of asthma exacerbations$527,947
R01 · FY2011 · HL · contact PI
Preventing fucose-dependent binding of aspergillus and pseudomonas to lung mucin$430,625
P50 · FY2011 · HL · contact PI
Histoblood group antigens, viruses & asthma excerbation$482,451
R01 · FY2008 · HL · contact PI
Histoblood group antigens, viruses & asthma excerbation$492,297
R01 · FY2007 · HL · contact PI
Histoblood group antigens, viruses & asthma excerbation$506,999
R01 · FY2006 · HL · contact PI
Histoblood group antigens, viruses &asthma excerbation$532,075
R01 · FY2005 · HL
T CELL INFLAMMATION AND MUCIN HYPERSECRETION IN COPD$331,875
R01 · FY2004 · HL
Gene Profiling in Lung Cells from Smokers$1,825
M01 · FY2004 · RR
T CELL INFLAMMATION AND MUCIN HYPERSECRETION IN COPD$331,875
R01 · FY2003 · HL
T CELL INFLAMMATION AND MUCIN HYPERSECRETION IN COPD$331,875
R01 · FY2002 · HL
GOBLET CELL DYSFUNCTION IN ASTHMA$216,082
R01 · FY2002 · HL
T CELL INFLAMMATION AND MUCIN HYPERSECRETION IN COPD$328,359
R01 · FY2001 · HL
GOBLET CELL DYSFUNCTION IN ASTHMA$211,986
R01 · FY2001 · HL
GOBLET CELL DYSFUNCTION IN ASTHMA$208,010
R01 · FY2000 · HL